| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1537-2995.2011.03375.X |
| P8608 | Fatcat ID | release_bs53oeiznjaqzhumjp3bfnxyzi |
| P698 | PubMed publication ID | 22074623 |
| P2093 | author name string | Henry C Fung | |
| Antonio Jimenez | |||
| Kent W Christopherson | |||
| P2860 | cites work | Cotransplantation of mesenchymal stem cells might prevent death from graft-versus-host disease (GVHD) without abrogating graft-versus-tumor effects after HLA-mismatched allogeneic transplantation following nonmyeloablative conditioning | Q43181730 |
| Transgenic expression of stromal cell-derived factor-1/CXC chemokine ligand 12 enhances myeloid progenitor cell survival/antiapoptosis in vitro in response to growth factor withdrawal and enhances myelopoiesis in vivo | Q43549436 | ||
| Stromal-derived factor 1 inhibits the cycling of very primitive human hematopoietic cells in vitro and in NOD/SCID mice | Q43863893 | ||
| Serious infections after unrelated donor transplantation in 136 children: impact of stem cell source | Q44004895 | ||
| Augmentation of umbilical cord blood (UCB) transplantation with ex vivo-expanded UCB cells: results of a phase 1 trial using the AastromReplicell System | Q44321385 | ||
| PSGL-1 participates in E-selectin-mediated progenitor homing to bone marrow: evidence for cooperation between E-selectin ligands and alpha4 integrin. | Q44451874 | ||
| Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia | Q44499780 | ||
| Surface fucosylation of human cord blood cells augments binding to P-selectin and E-selectin and enhances engraftment in bone marrow | Q44997562 | ||
| Cotransplantation of third-party mesenchymal stromal cells can alleviate single-donor predominance and increase engraftment from double cord transplantation | Q45869865 | ||
| Direct intrabone transplant of unrelated cord-blood cells in acute leukaemia: a phase I/II study | Q48480090 | ||
| Ex-vivo expansion of bone marrow progenitor cells for hematopoietic reconstitution following high-dose chemotherapy for breast cancer. | Q51463650 | ||
| Transplantation of ex-vivo culture-expanded parental haploidentical mesenchymal stem cells to promote engraftment in pediatric recipients of unrelated donor umbilical cord blood: results of a phase I-II clinical trial. | Q53443788 | ||
| Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy | Q56777948 | ||
| The Biology of Hematopoietic Stem Cells | Q58043095 | ||
| AMD3100 is a CXCR7 ligand with allosteric agonist properties | Q28236927 | ||
| Human mesenchymal stem cells modulate allogeneic immune cell responses | Q28288692 | ||
| Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study | Q29617267 | ||
| Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells | Q29618766 | ||
| Mesenchymal stem cells promote engraftment of human umbilical cord blood-derived CD34(+) cells in NOD/SCID mice | Q30165266 | ||
| Single-unit dominance after double-unit umbilical cord blood transplantation coincides with a specific CD8+ T-cell response against the nonengrafted unit | Q33627040 | ||
| The detection of donor-directed, HLA-specific alloantibodies in recipients of unrelated hematopoietic cell transplantation is predictive of graft failure | Q33780282 | ||
| A randomized multicenter comparison of bone marrow and peripheral blood in recipients of matched sibling allogeneic transplants for myeloid malignancies. | Q34144404 | ||
| Conditions controlling the proliferation of haemopoietic stem cells in vitro | Q34162126 | ||
| Peripheral blood stem cell versus bone marrow allotransplantation: does the source of hematopoietic stem cells matter? | Q34430882 | ||
| Prostaglandins in health and disease: an overview | Q34554050 | ||
| Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling | Q34668125 | ||
| Rapid mobilization of functional donor hematopoietic cells without G-CSF using AMD3100, an antagonist of the CXCR4/SDF-1 interaction | Q34772401 | ||
| The bicyclam AMD3100 story | Q35158014 | ||
| Serious infection risk and immune recovery after double-unit cord blood transplantation without antithymocyte globulin | Q35190671 | ||
| Long-term follow-up of patients who experienced graft failure postallogeneic progenitor cell transplantation. Results of a single institution analysis | Q35994849 | ||
| The chemokine SDF-1 is a chemoattractant for human CD34+ hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34+ progenitors to peripheral blood. | Q36376700 | ||
| Endothelial selectins and vascular cell adhesion molecule-1 promote hematopoietic progenitor homing to bone marrow | Q36735787 | ||
| Results of the Cord Blood Transplantation Study (COBLT): clinical outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with hematologic malignancies | Q36969812 | ||
| Acute graft-versus-host disease after unrelated donor umbilical cord blood transplantation: analysis of risk factors | Q37129657 | ||
| Umbilical cord blood transplantation: basic biology and clinical challenges to immune reconstitution | Q37131658 | ||
| Prostaglandin E2 enhances hematopoietic stem cell homing, survival, and proliferation | Q37209033 | ||
| Relapse risk after umbilical cord blood transplantation: enhanced graft-versus-leukemia effect in recipients of 2 units | Q37414733 | ||
| Prostaglandin E2 regulates vertebrate haematopoietic stem cell homeostasis | Q37416219 | ||
| Intra-BM injection to enhance engraftment after myeloablative umbilical cord blood transplantation with two partially HLA-matched units. | Q37505684 | ||
| Improving the outcome of cord blood transplantation: use of mobilized HSC and other cells from third party donors | Q37606554 | ||
| Improving outcomes of cord blood transplantation: HLA matching, cell dose and other graft- and transplantation-related factors | Q37606581 | ||
| Immune reconstitution after allogeneic transplantation and expanding options for immunomodulation: an update | Q37705707 | ||
| Current status of stem cell mobilization | Q37773388 | ||
| Ex vivo fucosylation to improve the engraftment capability and therapeutic potential of human cord blood stem cells | Q43024357 | ||
| P304 | page(s) | 125S-137S | |
| P577 | publication date | 2011-11-01 | |
| P1433 | published in | Transfusion | Q15758500 |
| P1476 | title | Cellular therapies supplement: strategies for improving transplant efficiency in the context of cellular therapeutics | |
| P478 | volume | 51 Suppl 4 |
Search more.